Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01866891
Other study ID # 2012.744
Secondary ID
Status Completed
Phase N/A
First received May 22, 2013
Last updated August 26, 2016
Start date April 2012
Est. completion date October 2015

Study information

Verified date August 2016
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Chronic kidney disease (CKD) is associated with high level of peripheral arterial disease (PAD). This could lead wounds, infections then amputations or deaths by impairment of the peripheral cutaneous perfusion. Medical therapies are presently unable to cure, but only slow down these disorders. Impact of exercise and lower extremity PAD rehabilitation is decreased by the significant inactivity of the chronic hemodialysis patients. Recently, many studies have shown several various favorable effects of the perdialytic physical activity. There is currently no data about effects of the perdialytic activity on the lower extremity perfusion. The aim of this clinical study is to show the impact of three months perdialytic cycling on the microcirculation, in chronic hemodialysis patients. Primary outcome will be the increase of cutaneous perfusion, assessed by measuring transcutaneous oxygen pressure (tcPO2) on about twenty patients.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients performing chronic hemodialysis for more than 3 months

- Adult aged > or = 18 years old

- Information letter delivered to subjects

- Written free informed consent

- Clinically stable patients

- Voluntary patients to perform 30 minutes cycling per dialysis session

- Social French Security Affiliated subjects

Exclusion Criteria:

- Subjects without inclusion criteria

- Pregnant women

- Subjects protected by the law

- Physical impossibility to achieve exercise

- Medical contraindication to perform physical exercise

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Three months of regular perdialytic physical activity (cycling)
Cycling, in lying position, at a rate of thirty minutes per dialysis session (three a week), regardless of performance

Locations

Country Name City State
France Hôpital Edouard Herriot Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increase of cutaneous lower extremity perfusion. TcPO2 will be performed at the inclusion and just after the end of the three month study period Yes
Secondary Vascular assessment : Doppler and Index of systolic blood pressure At the inclusion and after the end of the three month study period Yes
Secondary Related quality of life at the inclusion and after the end of the three month study period Yes
Secondary Appetite (score) at the inclusion and after the end of the three month study period Yes
Secondary Daily activity (Seven days pedometers) at the inclusion and after the end of the three month study period Yes
Secondary Protein intake (n-PCR) at the inclusion and after the end of the three month study period Yes
Secondary nutritional biological status (creatinin, albumin and transthyretin protein level) at the inclusion and after the end of the three month study period Yes
Secondary strength (handgrip test) at the inclusion and after the end of the three month study period Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06382701 - Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation N/A
Completed NCT04674930 - Effects of Exercise Program on Physical Functioning of Hemodialysis Patients. N/A
Recruiting NCT02245633 - Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients N/A
Recruiting NCT01970280 - Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients. Phase 4
Completed NCT06165211 - Nature-Based Sound Application For Hemodialysis Patients N/A
Completed NCT06106763 - Mandala Colouring On Anxiety, Depression, Pain And Quality of Life N/A
Completed NCT05693584 - The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients N/A
Completed NCT01932853 - Association Between Dose Dialysis by Kt and Mortality N/A
Completed NCT01273974 - The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients Phase 2/Phase 3
Completed NCT04139759 - THE EFFECT OF HAND AND FOOT MASSAGE ON FATIGUE IN HEMODIALYSIS PATIENTS N/A
Not yet recruiting NCT05574595 - Effect on Pain and Comfort Associated With Fistula Puncture N/A
Completed NCT04175652 - Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality N/A
Not yet recruiting NCT06314243 - The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients Phase 3
Completed NCT01596842 - Effect of Omega-3 Fatty Acid on Vitamin D Activation Phase 4
Enrolling by invitation NCT01896882 - Dietary Sodium Restriction in Hemodialysis Patients N/A
Completed NCT00638300 - Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD) N/A
Terminated NCT00259714 - Dialysate Sodium Individualization in Hemodialysis Phase 1
Completed NCT01846754 - Prevalence of Fatigue in Hemodialysis Patients N/A
Completed NCT00491868 - Clinical Study of R744 to Hemodialysis Patients Phase 3
Not yet recruiting NCT06449105 - The Effect of Mindfulness Compassionate Living Practice on Hemodialysis Patients N/A